(Q35013844)

5 August 2017

title

Age-specific occurrence of HPV16- and HPV18-related cervical cancer (English)

1 reference

5 August 2017

main subject

cervix uterine cancer

1 reference

1

Silvia de Sanjose

1 reference

5 August 2017

2

Cosette M Wheeler

1 reference

Francesc Xavier Bosch José

5 August 2017

7

object named as

F Xavier Bosch

2 references

ORCID Public Data File 2021

5 August 2017

10

Philip E Castle

1 reference

5 August 2017

Wim G V Quint

3

1 reference

5 August 2017

William C Hunt

4

1 reference

5 August 2017

Nancy E Joste

5

1 reference

5 August 2017

Laia Alemany

6

1 reference

5 August 2017

Retrospective International Survey and HPV Time Trends Study Group

8

1 reference

5 August 2017

Evan R Myers

9

1 reference

5 August 2017

language of work or name

1 reference

30 April 2013

1 reference

Cancer Epidemiology, Biomarkers & Prevention

5 August 2017

published in

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

1313-1318

1 reference

Recommendations on screening for cervical cancer

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Cervical carcinoma rates among young females in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4306595

Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002

25 October 2018

1 reference

12 December 2020

Description of the national situation of cervical cancer screening in the member states of the European Union

1 reference

12 December 2020

Practice improvement in cervical screening and management: symposium on management of cervical abnormalities in adolescents and young women

1 reference

12 December 2020

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up

1 reference

12 December 2020

10.1158/1055-9965.EPI-13-0053

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference